SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-229584
Filing Date
2023-09-06
Accepted
2023-09-06 16:05:36
Documents
16
Period of Report
2023-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d846509d8k.htm   iXBRL 8-K 36195
2 EX-10.1 d846509dex101.htm EX-10.1 26246
3 EX-10.2 d846509dex102.htm EX-10.2 22424
4 EX-99.1 d846509dex991.htm EX-99.1 13518
8 GRAPHIC g846509g0906021548486.jpg GRAPHIC 3106
  Complete submission text file 0001193125-23-229584.txt   246364

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA alxo-20230901.xsd EX-101.SCH 2862
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20230901_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20230901_pre.xml EX-101.PRE 10820
10 EXTRACTED XBRL INSTANCE DOCUMENT d846509d8k_htm.xml XML 3290
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 231239166
SIC: 2834 Pharmaceutical Preparations